What's new
Online survey to help tailor counselling for people taking APOE4 test
12 January 2026
Researchers at the University of Oxford and Imperial College London are looking for particpants to complete a 15-minute questionnaire to help develop appropriate counselling tools for people taking an APOE4 gene test. They want to make sure the information is clear, respectful, and relevant by gathering opinions and perspectives from a range of people with a close interest in or experience of dementia.
READ-OUT celebrates its first year by recruiting the 500th participant
6 January 2026
Alex McCreadie, a retired former soldier and health and safety professional, became the 500th participant in DPUK's #READ-OUT study. The study is evaluating the accuracy of tests diagnosing dementia to use in the NHS. He was recruited by ReMind UK in Bath, one of 21 sites already operating as part of the study. In 2026, 10 more locations will join the network, including sites as far north as Stornaway in the Outer Hebrides.
What next for GLP-1 receptor agonists and dementia?
9 December 2025
Novo Nordisk's EVOKE trial didn't meet its primary endpoint - semaglutide didn't slow cognitive decline in people with early Alzheimer's. But the results revealed something intriguing: reductions in biomarkers of neurodegeneration, inflammation, and tau protein. The drug does something to Alzheimer's biology - the question is when to use it.
Top partnership award for DPUK, Eli Lilly and NHS trusts biomarker collaboration
21 November 2025
Dementias Platform UK is delighted to announce that our biomarker pilot project, delivered in collaboration with Eli Lilly & Company, has won the prestigious HSJ Partnership of the Year Award 2025!
How is Dementias Platform UK enhancing research into dementia?
Watch this introductory video about Dementias Platform UK (DPUK) and how it is bringing together the best scientific minds and global leaders in the pharmaceutical industry to find new ways of detecting, treating and preventing dementia.
Get the DPUK newsletter
Sign up to subscribe to the DPUK newsletter.
Keep up to date with all that's going on at Dementias Platform UK. There are around 4 newsletters a year, which include news about developments in our infrastructure services, studies, partnerships and collaborations.
Social Media
We're currently active on LinkedIn, X (Twitter) and BlueSky where we post about every aspect of DPUK. Most of our news is shared on these channels first including jobs, new studies, programme's milestones, information on training, seminars and conferences.
Science feature
Charting the Ageing Brain: Insights from 46,000 MRI Scans
What happens inside our brains as we age? In a collaborative research study recently published in Mechanisms of Ageing and Development, researchers used UK Biobank data to create an unprecedented map of brain ageing—discovering why some regions are more vulnerable than others.
The DPUK Data Portal gives researchers rapid, secure access to multimodal datasets and millions of health research records.
Our Trials Delivery Framework matches public volunteers to the right dementia studies and has over 80 clinical sites across the UK.
DPUK's Experimental Medicine Incubator accelerates and de-risks the development of new treatments for dementia.
Work with us
Would you like to increase the international visibility of your data? Try our Data Portal.
Do you need well-characterised volunteers for your early-phase trial? Use our Trials Delivery Framework.
Is there a mechanism you would like to investigate? Explore our Experimental Medicine Incubator.